31
Participants
Start Date
May 23, 2018
Primary Completion Date
July 25, 2024
Study Completion Date
September 10, 2025
Rucaparib
one dose level (300 mg BID, 400 mg BID, 500 mg BID or 600 mg BID) concurrently with a 6-week course of radiotherapy and 4 additional weeks of maintenance rucaparib at the same dose level.
Radiotherapy
50 Gy in 2 Gy per fraction to the breast or chest wall with or without regional nodes plus a 10 Gy boost to the lumpectomy cavity, to a total dose of 60 Gy. A 10 Gy boost to the post-mastectomy scar is allowed at the discretion of the treating physician.
Memorial Sloan Kettering Cancer Center, New York
Memorial Sloan Kettering Westchester, Harrison
Memorial Sloan Kettering Nassau, Uniondale
Memorial Sloan Kettering Commack, Commack
Norwalk Hospital, Norwalk
Memorial Sloan Kettering at Basking Ridge, Basking Ridge
Memorial Sloan Kettering Monmouth, Middletown
Memorial Sloan Kettering Bergen, Montvale
Collaborators (1)
Clovis Oncology, Inc.
INDUSTRY
National Cancer Institute (NCI)
NIH
Memorial Sloan Kettering Cancer Center
OTHER